Cargando…
Disease-modifying drugs for multiple sclerosis and subsequent health service use
OBJECTIVE: We assessed the relationship between the multiple sclerosis (MS) disease-modifying drugs (DMDs) and healthcare use. METHODS: Persons with MS (aged ⩾18 years) were identified using linked population-based health administrative data in four Canadian provinces and were followed from the most...
Autores principales: | Ng, Huah Shin, Zhu, Feng, Kingwell, Elaine, Zhao, Yinshan, Yao, Shenzhen, Ekuma, Okechukwu, Svenson, Lawrence W, Evans, Charity, Fisk, John D, Marrie, Ruth Ann, Tremlett, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958569/ https://www.ncbi.nlm.nih.gov/pubmed/34949130 http://dx.doi.org/10.1177/13524585211063403 |
Ejemplares similares
-
Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022) -
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023) -
Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
por: Ng, Huah Shin, et al.
Publicado: (2022) -
Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study
por: Evans, Charity, et al.
Publicado: (2021) -
Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)